As per data from the Canadian Institute for Health Information, public drug programs spent USD 16.2 billion in 2021, indicating a rise of 7.4% from 2020. The North America brown commercial seaweed industry value is poised to depict over 8% CAGR from 2032 to 2032, driven by continuous R&D projects and sizeable investments in the pharmaceutical sector. Increase in pharma spending may spur brown seaweed supplement production in North America Poultry has also become the most consumed livestock commodity, especially in emerging and developing nations.īrowse key industry insights spread across 380 pages with 395 market data tables and 36 figures & charts from the report, “Brown Commercial Seaweed Market Size By Form (Wet, Dry), By End Use (Food, Animal Feed, Pharmaceutical, Cosmetics & Personal Care, Biofuels, Bioplastics, Biochemicals, Biorefineries), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023–2032” in detail along with the table of contents : Furthermore, the maintenance of diets rich in seaweed is associated with reduced body weight in poultry. Brown seaweed can lower the microbial load in the digestive tract and increase poultry meat and egg quality.

The poultry feed end-use segment is set to surpass USD 340 million by 2032, owing to its capability to improve the immune system of poultry livestock. Get more details on this report - Request Free Sample PDF

Advanced system care driver booster key